Improving the retention rate for residential treatment of substance abuse by sequential intervention for social anxiety.

通过社交焦虑的序贯干预提高药物滥用住院治疗的保留率。

• 批准号: LP0990162
• 负责人: A/Prof Petra Staiger
• 金额: $ 9.61万
• 依托单位: Deakin University
• 依托单位国家: 澳大利亚
• 项目类别: Linkage Projects
• 财政年份: 2010
• 资助国家: 澳大利亚
• 起止时间: 2010-03-30 至 2014-12-31
• 项目状态: 已结题
• 来源: https://dataportal.arc.gov.au/RGS/Web/Grants/LP0990162
• 关键词: Improving; retention; rate; residential; treatment

Alcohol and other drug use is a major social and medical problem, costing the Australian community an estimated $7.6 billion annually. Mental health disorders have been closely linked with increased illicit drug use and physical health problems. Social anxiety (SAD) is highly prevalent amongst individuals presenting with drug and alcohol use disorders. Evidence suggests that social anxiety symptoms may be responsible for promoting excessive drug use and may be a particularly influential factor in poor treatment retention rates and promoting relapse. Thus, the focus on improving treatment outcomes for individuals with comorbid anxiety and drug use disorders represents an area of considerable importance both nationally and internationally.

酒精和其他药物的使用是一个主要的社会和医疗问题，估计每年给澳大利亚社区造成76亿澳元的损失。心理健康障碍与非法药物使用和身体健康问题的增加密切相关。社交焦虑症（SAD）在患有药物和酒精使用障碍的个体中非常普遍。 有证据表明，社交焦虑症状可能是促进过度吸毒的原因，也可能是治疗保持率低和促进复吸的一个特别有影响力的因素。 因此，关注改善焦虑和药物使用障碍共病患者的治疗结果，在国内和国际上都是一个相当重要的领域。